Randomized, open-label, phase II trial of dostarlimab (TSR-042), as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation: ATOMICC study
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Oaknin, A.
Iglesias, M.
Alarcon, J. D.
Villacampa Javierre, G.
Gaba Garcia, L.
Santaballa, A.
Manso, L. M.
Romero, I.
Barretina Ginesta, M. P.
Churruca, C.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
